Featuring: Andrew Steele, MD, FRCPC, Tara L. Sedlak, MD, FRCPC
LEARNING OBJECTIVES:
Evaluate treatment options for
patients across the spectrum of
renal impairment
Address common concerns around
the use of NOACs in patients with
AF and CKD
Assess the impact of renal function
on efficacy and safety outcomes
Examine recent data on
pharmacokinetics, CKD progression,
and clinical outcomes with regard
to anticoagulation strategies in
NVAF patients with moderate to
severe kidney disease
